- Home
- POWW vs AMRN Comparison
POWW vs AMRN Comparison
Compare POWW & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | POWW | AMRN |
|---|---|---|
| Founded | 1990 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 287.9M |
| IPO Year | 2018 | 1998 |
Fundamental Metrics
Financial Performance| Metric | POWW | AMRN |
|---|---|---|
| Price | $2.22 | $13.68 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 2 | 1 |
| Target Price | $2.40 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 435.5K | 79.0K |
| Earning Date | 02-09-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 95.61 | 55.00 |
| EPS | ★ 0.02 | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $14.56 | N/A |
| Revenue Next Year | $0.50 | $1.26 |
| P/E Ratio | $108.75 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $1.39 | $12.96 |
| 52 Week High | $2.67 | $20.90 |
Technical Indicators
Market Signals| Indicator | POWW | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 40.75 |
| Support Level | $1.96 | $13.41 |
| Resistance Level | $2.46 | $14.50 |
| Average True Range (ATR) | 0.05 | 0.38 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 92.59 | 31.54 |
Price Performance
Historical ComparisonAbout POWW AMMO Inc.
Outdoor Holding Co the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketplace segment consists of the GunBroker e-commerce marketplace. The company generates the majority of its revenue from the Ammunition segment.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.